These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35869875)

  • 1. Impact of the COVID-19 pandemic on hospital antimicrobial consumption in Croatia.
    Vlahović-Palčevski V; Rubinić I; Payerl Pal M
    J Antimicrob Chemother; 2022 Sep; 77(10):2713-2717. PubMed ID: 35869875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns.
    Nakitanda AO; Karlsson P; Löfling L; Cesta CE; Odsbu I
    BMC Infect Dis; 2022 May; 22(1):492. PubMed ID: 35610597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications from ESAC-Net and WHO Europe.
    Robertson J; Vlahović-Palčevski V; Iwamoto K; Högberg LD; Godman B; Monnet DL; Garner S; Weist K; ;
    Front Pharmacol; 2021; 12():639207. PubMed ID: 34220495
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018-2021.
    Murungi M; Ndagije HB; Kiggundu R; Kesi DN; Waswa JP; Rajab K; Barigye M; Serwanga A; Manirakiza L; Kasujja H; Kaweesi D; Joshi MP; Namugambe J; Konduri N
    J Infect Public Health; 2023 Dec; 16 Suppl 1():45-51. PubMed ID: 37926595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the COVID-19 pandemic on antibiotic consumption and prevalence of pathogens in primary and secondary healthcare settings in Northern Ireland.
    Aldeyab MA; Crowe W; Karasneh RA; Patterson L; Sartaj M; Ewing J; Lattyak WJ; Al-Azzam S; Araydah M; Darwish Elhajji F; Kabbaha S; Conway BR; Conlon-Bingham G; Farren D; Scott M
    Br J Clin Pharmacol; 2023 Sep; 89(9):2851-2866. PubMed ID: 37160725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic consumption in Belgian acute care hospitals: analysis of the surveillance methodology, consumption evolution 2003 to 2016 and future perspectives.
    Vandael E; Magerman K; Coenen S; Goossens H; Catry B
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020.
    Bogdanić N; Močibob L; Vidović T; Soldo A; Begovać J
    PLoS One; 2022; 17(2):e0263437. PubMed ID: 35108332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Use Fell Substantially in Japan in 2020-The COVID-19 Pandemic May Have Played a Role.
    Ono A; Koizumi R; Tsuzuki S; Asai Y; Ishikane M; Kusama Y; Ohmagari N
    Int J Infect Dis; 2022 Jun; 119():13-17. PubMed ID: 35306203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis.
    Khan S; Hasan SS; Bond SE; Conway BR; Aldeyab MA
    Expert Rev Anti Infect Ther; 2022 May; 20(5):749-772. PubMed ID: 34895002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A paediatric hospital care AMC report for Northern Ireland.
    Mallett P; McMichael D; Hsia Y; Moriarty P
    J Antimicrob Chemother; 2022 Jun; 77(7):2024-2029. PubMed ID: 35451012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance--antibiotic DU90% profiles with bacterial resistance rates: a visual presentation.
    Mimica Matanovic S; Bergman U; Vukovic D; Wettermark B; Vlahovic-Palcevski V
    Int J Antimicrob Agents; 2010 Oct; 36(4):369-73. PubMed ID: 20688486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the COVID-19 pandemic on community antibiotic consumption in the EU/European Economic Area: a changepoint analysis.
    Vermeulen H; Hens N; Catteau L; Catry B; Coenen S
    J Antimicrob Chemother; 2023 Oct; 78(10):2572-2580. PubMed ID: 37671788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial consumption in an acute NHS Trust during the COVID-19 pandemic: intervention time series analysis.
    Khan S; Bond SE; Lee-Milner J; Conway BR; Lattyak WJ; Aldeyab MA
    JAC Antimicrob Resist; 2024 Feb; 6(1):dlae013. PubMed ID: 38328263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensification of antibiotic use within acute care hospitals in the Netherlands.
    Kwint HM; van der Linden PD; Roukens MM; Natsch S;
    J Antimicrob Chemother; 2012 Sep; 67(9):2283-8. PubMed ID: 22635524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial utilization and bacterial resistance at three different hospitals.
    Vlahović-Palcevski V; Morović M; Palcevski G; Betica-Radić L
    Eur J Epidemiol; 2001; 17(4):375-83. PubMed ID: 11767964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in antimicrobial use associated with a multifaceted antimicrobial stewardship programme in a tertiary teaching hospital in Shanghai: a segmented regression analysis.
    Liu YX; Liang C; Yang Y; Le KJ; Zhang ZL; Gu ZC; Zhong H; Lin HW; Luo HJ
    Ann Palliat Med; 2021 Jul; 10(7):7360-7369. PubMed ID: 34353033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-infectives for systemic use prescribed in a Spanish hospital between 2009-2013.
    March Rosselló GA; Mora AA; Pérez Rubio A; Eiros Bouza JM
    Infez Med; 2016; 24(1):18-23. PubMed ID: 27031892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilisation of antimicrobials used to treat bacterial pneumonia in principal referral hospitals during the COVID-19 pandemic, Australia, 2020.
    Connor E; Rasiah K; Hillock N
    Commun Dis Intell (2018); 2022 Feb; 46():. PubMed ID: 35168505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial consumption at Auckland City Hospital: 2006-2009.
    Ticehurst R; Thomast M
    N Z Med J; 2011 Apr; 124(1332):9-20. PubMed ID: 21747419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial consumption and drug utilization patterns among COVID-19 and non-COVID-19 patients.
    Antunes BBP; Silva AAB; Nunes PHC; Martin-Loeches I; Kurtz P; Hamacher S; Bozza FA
    J Antimicrob Chemother; 2023 Mar; 78(3):840-849. PubMed ID: 36740939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.